These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


216 related items for PubMed ID: 27118475

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Engineered fusokine GIFT4 licenses the ability of B cells to trigger a tumoricidal T-cell response.
    Deng J, Yuan S, Pennati A, Murphy J, Wu JH, Lawson D, Galipeau J.
    Cancer Res; 2014 Aug 01; 74(15):4133-44. PubMed ID: 24938765
    [Abstract] [Full Text] [Related]

  • 3. GM-CSF and IL-4 Fusion Cytokine Induces B Cell-Dependent Hematopoietic Regeneration.
    Deng J, Li Y, Pennati A, Yuan S, Wu JH, Waller EK, Galipeau J.
    Mol Ther; 2017 Feb 01; 25(2):416-426. PubMed ID: 28153092
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo.
    Di Ianni M, Moretti L, Terenzi A, Bazzucchi F, Del Papa B, Bazzucchi M, Ciurnelli R, Lucchesi A, Sportoletti P, Rosati E, Marconi PF, Falzetti F, Tabilio A.
    Cytotherapy; 2009 Feb 01; 11(1):86-96. PubMed ID: 19153855
    [Abstract] [Full Text] [Related]

  • 10. Autologous antileukemic immune response induced by chronic lymphocytic leukemia B cells expressing the CD40 ligand and interleukin 2 transgenes.
    Takahashi S, Rousseau RF, Yotnda P, Mei Z, Dotti G, Rill D, Hurwitz R, Marini F, Andreeff M, Brenner MK.
    Hum Gene Ther; 2001 Apr 10; 12(6):659-70. PubMed ID: 11426465
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Dendritic cells from chronic lymphocytic leukemia patients are normal regardless of Ig V gene mutation status.
    Messmer D, Telusma G, Wasil T, Messmer BT, Allen S, Rai KR, Chiorazzi N.
    Mol Med; 2004 Apr 10; 10(7-12):96-103. PubMed ID: 16113842
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Generation of B-cell chronic lymphocytic leukemia (B-CLL)-reactive T-cell lines and clones from HLA class I-matched donors using modified B-CLL cells as stimulators: implications for adoptive immunotherapy.
    Hoogendoorn M, Wolbers JO, Smit WM, Schaafsma MR, Barge RM, Willemze R, Falkenburg JH.
    Leukemia; 2004 Jul 10; 18(7):1278-87. PubMed ID: 15116118
    [Abstract] [Full Text] [Related]

  • 17. Dendritic cells in patients with non-progressive B-chronic lymphocytic leukaemia have a normal functional capability but abnormal cytokine pattern.
    Rezvany MR, Jeddi-Tehrani M, Biberfeld P, Söderlund J, Mellstedt H, Osterborg A, Rabbani H.
    Br J Haematol; 2001 Nov 10; 115(2):263-71. PubMed ID: 11703320
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Interleukin-21 receptor (IL-21R) is up-regulated by CD40 triggering and mediates proapoptotic signals in chronic lymphocytic leukemia B cells.
    de Totero D, Meazza R, Zupo S, Cutrona G, Matis S, Colombo M, Balleari E, Pierri I, Fabbi M, Capaia M, Azzarone B, Gobbi M, Ferrarini M, Ferrini S.
    Blood; 2006 May 01; 107(9):3708-15. PubMed ID: 16391014
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.